^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MLPH overexpression

    i
    Other names: MLPH, Melanophilin, Exophilin-3, Slp Homolog Lacking C2 Domains A, Synaptotagmin-Like Protein 2a, L(1)-3Rk, SLAC2-A, Slac-2a, SlaC2-A, SLAC2A, L1Rk3, Ln
    Entrez ID:
    79083
    over2years
    Overexpression of MLPH in Rectal Cancer Patients Correlates with a Poorer Response to Preoperative Chemoradiotherapy and Reduced Patient Survival. (PubMed, Diagnostics (Basel))
    After uni- and multi-variable analysis of five-year survival, MLPH expression was still associated with lower DSS (hazard ratio (HR), 10.110; 95% confidence interval (CI), 2.178-46.920; p = 0.003) and MeFS (HR, 5.621; 95% CI, 1.762-17.931; p = 0.004). In conclusion, identifying MLPH expression could help to predict the response to chemoradiation and survival, and aid in personal therapeutic modification.
    Clinical • Journal
    |
    MLPH (Melanophilin)
    |
    MLPH overexpression